CAMBELL INTERNATIONAL HOLDING CORP. (BIMT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
UNIT NO. 5784 BANGKOK, 10500 |
| State of Incorp. | NV |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 6/30/2023 | 6/30/2022 | 6/30/2019 | 6/30/2018 | 6/30/2017 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 286 | 1 | 19 | 38 | ||||
| Cash and cash equivalent | 286 | 1 | 19 | 38 | ||||
| Receivables | 62 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 369 | |||||||
| Inventory | 369 | |||||||
| Prepaid expense | 108 | 1 | ||||||
| Other current assets | ||||||||
| Other undisclosed current assets | 19 | |||||||
| Total current assets: | 845 | 2 | 19 | 38 | ||||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 49 | 0 | 3 | 3 | ||||
| Other undisclosed noncurrent assets | 2 | 19 | ||||||
| Total noncurrent assets: | 49 | 3 | 22 | 3 | ||||
| Other undisclosed assets | (4) | (39) | ||||||
| TOTAL ASSETS: | 893 | 0 | 3 | 41 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 77 | 2 | 6 | 0 | ||||
| Employee-related liabilities | ✕ | ✕ | 4 | |||||
| Accounts payable | 17 | 2 | 1 | 0 | ||||
| Accrued liabilities | 61 | |||||||
| Debt | 64 | 4 | ||||||
| Due to related parties | ✕ | 7 | ||||||
| Other undisclosed current liabilities | 3,769 | 0 | ||||||
| Total current liabilities: | 3,910 | 9 | 6 | 4 | ||||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 14 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 9 | |||
| Accounts payable and accrued liabilities | 3 | |||||||
| Due to related parties | ✕ | 2 | ||||||
| Other undisclosed noncurrent liabilities | (3) | 19 | ||||||
| Total noncurrent liabilities: | (3) | 19 | 14 | |||||
| Total liabilities: | 3,910 | 9 | 3 | 22 | 14 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | (3,016) | (9) | (3) | 19 | 27 | |||
| Preferred stock | 10 | |||||||
| Common stock | 7 | 6 | 6 | |||||
| Common stock, value, subscriptions | 5,000 | |||||||
| Additional paid in capital | 31 | 24 | 24 | 24 | ||||
| Accumulated other comprehensive income | 280 | |||||||
| Accumulated deficit | (3,296) | (47) | (33) | (11) | (3) | |||
| Stockholders' equity note, subscriptions receivable | (17) | |||||||
| Other undisclosed equity, attributable to parent | (4,994) | 6 | ||||||
| Other undisclosed equity | (3) | (22) | ||||||
| Total equity: | (3,016) | (9) | (6) | (4) | 27 | |||
| TOTAL LIABILITIES AND EQUITY: | 893 | (3) | 19 | 41 | ||||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 6/30/2023 | 6/30/2022 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 463 | 18 | 11 | ||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 11 | ||
| Cost of revenue | (371) | ||||||
| Other undisclosed gross profit | (3) | ||||||
| Gross profit: | 92 | 15 | 11 | ||||
| Operating expenses | (1,204) | (7) | (22) | 8 | (13) | ||
| Other undisclosed operating loss | (31) | ||||||
| Operating loss: | (1,112) | (7) | (22) | (8) | (2) | ||
| Nonoperating income (Other Nonoperating income) | 16 | ||||||
| Loss from continuing operations before income taxes: | (1,096) | (7) | (22) | (8) | (2) | ||
| Income tax benefit | 0 | ||||||
| Other undisclosed income from continuing operations | |||||||
| Loss from continuing operations: | (1,096) | (7) | (22) | (8) | (2) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (7) | (22) | (8) | (2) | |
| Net loss available to common stockholders, diluted: | (1,096) | (7) | (22) | (8) | (2) | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 6/30/2023 | 6/30/2022 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (1,096) | (7) | (22) | (8) | (2) | ||
| Comprehensive loss: | (1,096) | (7) | (22) | (8) | (2) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 254 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (842) | (7) | (22) | (8) | (2) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.